Genetic variants are major determinants of CSF antibody levels in multiple sclerosis
An Goris(University of Cambridge), Hanne F. Harbo, Christian Sindic(Cliniques Universitaires Saint-Luc), Sandra D’Alfonso(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Jeannette Lechner‐Scott(John Hunter Hospital), Tomas Olsson(Karolinska University Hospital), Achim Berthele, Steffan D. Bos(Oslo University Hospital), Allan G. Kermode(Murdoch University), Benjamin Knier(Evangelisches Diakoniekrankenhaus), Bernhard Hemmer(Munich Cluster for Systems Neurology), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Ine Pauwels(KU Leuven), Sunny Malhotra(Universitat Autònoma de Barcelona), Jan Aarseth(Haukeland University Hospital), Melissa Sorosina, Pierre‐Antoine Gourraud, Poul Erik Jensen(University of Copenhagen), Simon Broadley(Griffith University), Maurizio Leone(Mario Negri Institute for Pharmacological Research), Jennifer Pérez‐Boza(University of Liège), Jan Hillert(Karolinska University Hospital), Mark Slee(Flinders University), Giuseppe Liberatore, Kjell‐Morten Myhr, Bettina Kulle Andreassen(Cancer Registry of Norway), Bruce Taylor(University of London), Sahl Khalid Bedri(Karolinska Institutet), Pål Berg‐Hansen(Oslo University Hospital), Ingrid Kockum(Karolinska Institutet), Lars Alfredsson(University of Helsinki), Kelly Hilven(KU Leuven), Stephen Sawcer(University of Cambridge), Elisabeth Gulowsen Celius(Oslo University Hospital), Vincent Van Pesch(Cliniques Universitaires Saint-Luc), Helle Bach Søndergaard, Filippo Martinelli Boneschi(Ollscoil na Gaillimhe – University of Galway), Manuel Comabella(Universitat Autònoma de Barcelona), Bénédicte Dubois(University of California, San Francisco), Nadia Barizzone(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Viola Biberacher(TUM Klinikum), Annette Oturai, Dorothea Buck, Finn Sellebjerg(Kaiser Permanente), Marte W. Gustavsen(Oslo University Hospital), Brechtje van Son(KU Leuven)
Cited by 67
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
|Nature|2011|2.8k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k